2.8K
Downloads
39
Episodes
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life.
Episodes
Friday Jun 11, 2021
Friday Jun 11, 2021
Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center clinical trial utilizing engineered t-cell therapy similar to CAR-T but better known as TRuC-T therapy (stands for TCR Fusion Construct T cells). While CAR-T cell therapy engineers the patient's own T-cells with chimeric antigen receptors (CARs), Truc-t therapy engineers T-cell receptors (TCRs). Dr. Johnson is a thoracic medical oncologist and is the program director of Lung Cancer Research at Sarah Cannon Cancer Center. Learn more about MesoTV at www.curemeso.org/mesotv.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.